Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Shanghai MicroPort MedBot Group Co Ltd
2252Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. It also offers spine surgical robots for spine surgery; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery. In addition, it manufactures parts of surgical robot devices; engages in assembly and distribution of surgical robot devices; research and development of system, as well as investment activities. Shanghai MicroPort MedBot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. The company operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd. Address: Building 1, Shanghai, China
Analytics
Precio Objetivo de WallStreet
137.73 HKDRelación P/E
–Rentabilidad por dividendo
–Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave 2252
Análisis de dividendos 2252
Aumento del dividendo durante 5 años
–Crecimiento continuo
–Ratio de pago medio en 5 años
–Tendencia del payout 2252
Valoración de la acción 2252
Finanzas 2252
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |